Interní Med. 2007; 9(4): 170-174

Peripheral vascular disease of lower extremities

MUDr. Dalibor Musil Ph.D
Cévní ambulance a Ústav patologické fyziologie LF UP a FN Olomouc

Peripheral vascular disease (PVD) of lower extremities is an atherothrombotic syndrome accompanied by a progressive narrowing of arteries of lower extremities. It is an important indicator of diffuse arterial involvement. The disease may be asymptomatic or symptomatic. Principle risk factors for PVD of lower extremities are advanced age, smoking, and diabetes mellitus. Further risk factors are hypertension, dyslipidemia, male sex, high plasmatic levels of homocystein, fibrinogen and glucose, history of myocardial infarction, TIA, stroke and heart failure. A classical example of PVD of lower extremities in a so far asymptomatic patient is a presentation with intermittent claudications. A critical limb ischemia describes chronic ischemic pain of a lower extremity at rest, ulcerations or gangrene of peripheral parts of a lower extremity. An acute limb ischemia is an urgent situation caused by a sudden occlusion of an artery by a thrombosis, embolus or a mechanical cause. Diagnosis of PVD of lower extremities is based on a history, presence of symptoms, and on ultrasound examination (pencil continuous Doppler, colour duplex ultrasonography). The primary goal of PVD treatment is to decrease cardiovascular morbidity and mortality by an aggressive intervention of risk factors. It is also necessary to prescribe an antiplatelet agent and provide a symptomatic relief pharmacologically and by intervention. The basic pharmacologic treatment is the use of antiplatelet agents (aspirin or clopidogrel), vasodilatant naftidrofuryl and statins. Regular exercise can prolong claudication intervals by up to 150%. If the effect of conservative therapy is insufficient or in the case of disease progression if the anatomical finding is suitable, we indicate an intervention – either endovascular (PTA) or surgical. In acute arterial occlusions it is possible to use a thrombolytic treatment, percutaneous aspirational thrombembolectomy (PAT) or mechanical thrombectomy.

Keywords: peripheral vascular disease of lower extremities, risk factors, clinical picture, treatment, ankle brachial index, colour duplex sonography

Published: June 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Musil D. Peripheral vascular disease of lower extremities. Interní Med. 2007;9(4):170-174.
Download citation

References

  1. Antiplatelet Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ, 2002; 324: 71-86. Go to original source... Go to PubMed...
  2. Barnhorst DA, Barner HB. Prevalence of congenitally absent pedal pulses N Engl J Med, 1968; 278: 264-265. Go to original source... Go to PubMed...
  3. Belch JJF, et al. Critical issues in peripheral arterial disease detection and management, Arch Intern Med, 2003; 163: 884-892. Go to original source... Go to PubMed...
  4. Bulvas M. Akutní uzávěry tepen a bypassů zásobujících dolní končetiny. In: Angiologie 2006, trendy soudobé angiologie. Svazek 1, Galén 2006: 27-41.
  5. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischemic events (APRIE). Lancet, 1996; 348: 1329-1339. Go to original source... Go to PubMed...
  6. D´Hooge D, Lehert P, Clement DL. Naftidrofuryl in quality of life (NIQOL): a Belgium study. Int Angol, 2001; 20: 288-294.
  7. Herman J. Chirurgická léčba claudicatio intermittens. In: Angiologie 2006, trendy soudobé angiologie. Svazek 1, Galén 2006: 23-25.
  8. Hirsch AT, Halverson SL, et al. Peripheral arterial disease detection, awarness, and treatment in primary care. JAMA, 2001; 286: 1317-1324. Go to original source... Go to PubMed...
  9. Chochola M, Vařejka P, Heller S. Možnosti intervenční léčby onemocnění tepen dolních končetin. Interní medicína pro praxi, 6, 2004; 11: 542-546.
  10. McKenna M, Wolfson S, Kuller R, The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis, 1991; 87: 119-128. Go to original source... Go to PubMed...
  11. Mohler ER. Peripheral arterial disease, Arch Intern Med, 2003; 163: 2306-2314. Go to original source... Go to PubMed...
  12. Piťhová P. Syndrom diabetické nohy ischemické etiologie a efekt léčby alprostadilem. Interní medicína pro praxi, 6, 2004; 8: 389-391.
  13. Roztočil K. Medikamentózní léčba u nemocných s klaudikacemi. In: Angiologie 2006, trendy soudobé angiologie. Svazek 1, Galen, s. 15-18.
  14. Spáčil J, Svobodová J. Význam rehabilitace u nemocných s klaudikacemi. In: Angiologie 2006, trendy soudobé angiologie. Svazek 1, Galén, s. 19-21.
  15. Staněk F. Ischemická choroba dolních končetin - chronické formy. In: Karetová D, Staněk F. Angiologie pro praxi, Maxdorf, 2001: 21-67.
  16. Weitz JI, Clagett GP, et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation, 1996; 94: 3026-3049. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.